Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Shimazaki

Showing results (171-180 of 189) with videos related to

Pageof 19
Sort By:
European Journal of Haematology|July 1, 1997
Effects of thrombopoietin (c-mpl ligand) on growth of blast cells from patients with transient abnormal myelopoiesis and acute myeloblastic leukemiaH Hirai, C Shimazaki, N Yamagata, et al.
British Journal of Haematology|August 6, 2000
Induction therapy consisting of alternating cycles of ranimustine, vincristine, melphalan, dexamethasone and interferon alpha (ROAD-IN) and a randomized comparison of interferon alpha maintenance in multiple myeloma: a co-operative study in JapanM Wada, H Mizoguchi, S I Kuriya, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 1, 1979
[A case of Clonorchis infection during the anti-leukemic chemotherapy (author's transl)]C Shimazaki, K Ri, K Osamura, et al.
International Journal of Hematology|October 20, 2000
Combination chemotherapy with risk factor-adjusted dose attenuation for high-risk myelodysplastic syndrome and resulting leukemia in the multicenter study of the Japan Adult Leukemia Study Group (JALSG): results of an interim analysisT Okamoto, A Kanamaru, C Shimazaki, et al.
Bone Marrow Transplantation|December 3, 2003
Allogeneic peripheral blood stem cell transplantation from two- or three-loci-mismatched related donors in adult Japanese patients with high-risk hematologic malignanciesS Yamasaki, Y Ohno, S Taniguchi, et al.
British Journal of Haematology|July 11, 2000
Expression of T-cell-associated antigens in B-cell non-Hodgkin's lymphomaT Inaba, C Shimazaki, T Sumikuma, et al.
Bone Marrow Transplantation|August 26, 1998
Allogeneic peripheral blood stem cell transplantation for standard-risk leukemia. A multicenter pilot study: Japanese experience. Japan Blood Cell Transplantation Study GroupM Harada, K Shinagawa, T Kawano, et al.
Bone Marrow Transplantation|January 18, 2005
Isolation and transplantation of highly purified autologous peripheral CD34+ progenitor cells: purging efficacy, hematopoietic reconstitution in non-Hodgkin's lymphoma (NHL): results of Japanese phase II studyY Imai, T Chou, K Tobinai, et al.
European Journal of Haematology|July 29, 2000
Prognostic value of p53 gene mutations and the product expression in de novo acute myeloid leukemiaY Nakano, T Naoe, H Kiyoi, et al.
Leukemia|February 13, 2002
Prognostic significance of the null genotype of glutathione S-transferase-T1 in patients with acute myeloid leukemia: increased early death after chemotherapyT Naoe, Y Tagawa, H Kiyoi, et al.
Pageof 19

Showing results (171-180 of 189) with videos related to

Sort By:
Pageof 19
European Journal of Haematology|July 1, 1997
Effects of thrombopoietin (c-mpl ligand) on growth of blast cells from patients with transient abnormal myelopoiesis and acute myeloblastic leukemiaH Hirai, C Shimazaki, N Yamagata, et al.
British Journal of Haematology|August 6, 2000
Induction therapy consisting of alternating cycles of ranimustine, vincristine, melphalan, dexamethasone and interferon alpha (ROAD-IN) and a randomized comparison of interferon alpha maintenance in multiple myeloma: a co-operative study in JapanM Wada, H Mizoguchi, S I Kuriya, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 1, 1979
[A case of Clonorchis infection during the anti-leukemic chemotherapy (author's transl)]C Shimazaki, K Ri, K Osamura, et al.
International Journal of Hematology|October 20, 2000
Combination chemotherapy with risk factor-adjusted dose attenuation for high-risk myelodysplastic syndrome and resulting leukemia in the multicenter study of the Japan Adult Leukemia Study Group (JALSG): results of an interim analysisT Okamoto, A Kanamaru, C Shimazaki, et al.
Bone Marrow Transplantation|December 3, 2003
Allogeneic peripheral blood stem cell transplantation from two- or three-loci-mismatched related donors in adult Japanese patients with high-risk hematologic malignanciesS Yamasaki, Y Ohno, S Taniguchi, et al.
British Journal of Haematology|July 11, 2000
Expression of T-cell-associated antigens in B-cell non-Hodgkin's lymphomaT Inaba, C Shimazaki, T Sumikuma, et al.
Bone Marrow Transplantation|August 26, 1998
Allogeneic peripheral blood stem cell transplantation for standard-risk leukemia. A multicenter pilot study: Japanese experience. Japan Blood Cell Transplantation Study GroupM Harada, K Shinagawa, T Kawano, et al.
Bone Marrow Transplantation|January 18, 2005
Isolation and transplantation of highly purified autologous peripheral CD34+ progenitor cells: purging efficacy, hematopoietic reconstitution in non-Hodgkin's lymphoma (NHL): results of Japanese phase II studyY Imai, T Chou, K Tobinai, et al.
European Journal of Haematology|July 29, 2000
Prognostic value of p53 gene mutations and the product expression in de novo acute myeloid leukemiaY Nakano, T Naoe, H Kiyoi, et al.
Leukemia|February 13, 2002
Prognostic significance of the null genotype of glutathione S-transferase-T1 in patients with acute myeloid leukemia: increased early death after chemotherapyT Naoe, Y Tagawa, H Kiyoi, et al.
Pageof 19